Full Papers
Pyridine (40 mg, 0.5 mmol) was added dropwise to alcohol
0.5 mmol) and triphosgene (75 mg, 0.25 mmol) in CH Cl (10 mL),
4.90–4.80 (m, 1H), 1.82–1.63 (m, 2H), 1.41–1.36 (m, 3H), 1.00 (t, J=
13
(
7.5 Hz, 3H); C NMR (CDCl , 100 MHz): d=158.4, 155.1, 154.4,
2
2
3
and the mixture was stirred at room temperature for 2 h to afford
the chlorocarbonate in CH Cl . A mixture of DMAP (25 mg,
152.1, 126.3, 122.8, 120.0, 118.4, 115.3, 111.2, 110.5, 78.8, 28.7, 19.2,
9.5; UV/Vis (lmax, nm, phosphate buffer pH 7.4, loge): 215 (3.8), 285
(3.7), 315 (3.7); elemental analysis calcd (%) for C H F O : C 54.55,
2
2
0
.2 mmol), Et N (0.42 mL, 3 mmol), and 7-hydroxy-4-methyl-2H-
3
15 13
3
5
chromen-2-one (176 mg, 1 mmol) or 7-hydroxy-4-trifluoromethyl-
H-chromen-2-one (230 mg, 1 mmol) in anhydrous CH Cl2 (2 mL)
H 3.97; found: C 54.75, H 4.02.
2
2
Enzyme assay: Substrates were prepared as stock solutions
was slowly added to the CH Cl solution of chlorocarbonate cooled
2
2
(
5 mm) in acetonitrile, and tested with commercially available lipas-
to 08C. The mixture was stirred for 2 h. The resulting suspension
was diluted with CH Cl (10 mL) and then HCl (10 mL, 1m). The or-
es and esterases. Substrate (50 mm) was added to enzyme (100 mg)
in a phosphate buffer (2 mL, 100 mm, pH 7.4). The fluorescence
time profile was recorded in a cuvette in an F7000 spectrofluorom-
eter (Shimazu). The fluorescence data were acquired over one
hour, which was sufficient for completion of the reaction with the
more reactive enzymes. Fluorescence data were converted into 4-
metylumbelliferone and 4-trifluoromethylumbelliferone concentra-
tions by means of a calibration curve. The linear portion of the
curve was used to obtain the reaction rate.
2
2
ganic phase was separated, dried over MgSO , and evaporated
4
under reduced pressure. The crude product was purified by
column chromatography on silica gel (CH Cl /MeOH, 99:1, v/v).
2
2
(R)-2-Butyl-(2-oxo-4-methyl-2H-chromen-7-yl) carbonate (R)-1:
The procedure was applied starting with (R)-butan-2-ol (74 mg,
1
2
.0 mmol) and 7-hydroxy-4-methyl-2H-chromen-2-one (352 mg,
mmol) to yield carbonate (R)-5 as a white solid; yield 130.5 mg
1
(
47%); m.p. 51–548C; [a] =À11.9 (c=1.0, CHCl ); H NMR (CDCl ,
À1
D
3
3
Larger-scale procedure: Equimolar (R)-1 and (S)-1 (4 mgmL )
4
00 MHz): d=7.61 (d, J=8.8 Hz, 1H), 7.22 (d, J=2.2 Hz, 1H), 7.17
were diluted in PBS (4 mL, 100 mm, pH 7.4) with acetonitrile (80:20,
(
dd, J =8.7 Hz, J =2.3 Hz, 1H), 6.27 (d, J=1.2 Hz, 1H), 4.90–4.78
À1
1
2
v/v). Enzyme (4 mgmL ) was added, and the mixture was placed
(
m, 1H), 2.44 (d, J=1.2 Hz, 3H), 1.81–1.62 (m, 2H), 1.37 (d, J=
on a shaker; the reactions lasted from one to four days. The mix-
ture was extracted with ethyl acetate, the organic phase was sepa-
rated, and solvents were evaporated. The mixture was analyzed by
1
3
6
1
7
.4 Hz, 3H), 1.00 (t, J=7.5 Hz, 3H); C NMR (CDCl , 100 MHz): d=
3
60.4, 154.1, 153.4, 152.4, 151.8, 125.4, 117.8, 117.4, 114.5, 109.9,
8.4, 28.7, 19.2, 18.7, 9.5; UV/Vis (lmax, nm, phosphate buffer
HPLC with a Chiralpak AD-H column. Retention times: (R)-1 t =
R
pH 7.4, loge): 215 (4.1), 275 (3.9) 310 (3.9); elemental analysis calcd
%) for C H O : C 65.21, H 5.84; found: C 65.30, H 5.85; HPLC
1
0.8 min, (S)-1 t =12.1 min. E values were calculated from E=
R
(
1
5
16
5
ln[(1Àc)(1Àee )]/ln[(1Àc)(1+ee )], where c is conversion, and ee is
s
s
s
analysis t =10.8 min (AD-H Chiralpak).
R
the enantiomeric excess of unreacted substrate. Quick E values
were calculated from E=(V /V )/(V /V ), where the hydrolysis rate
S
ref
R
ref
(S)-2-Butyl-(2-oxo-4-methyl-2H-chromen-7-yl) carbonate (S)-1:
for the reference was replaced by a second pseudoenantiomer rate
The procedure was applied starting with (S)-butan-2-ol (74 mg,
(
e.g., E=((S)-1/(R)-2)/((R)-1/(S)-2), if V >V ).
S R
1
2
.0 mmol) and 7-hydroxy-4-methyl-2H-chromen-2-one (352 mg,
mmol) to yield carbonate (S)-5 as a white solid; yield 108.9 mg
1
(
39%); m.p. 51–548C; [a] =+13.0 (c=1.0, CHCl ); H NMR (CDCl ,
D
3
3
Acknowledgements
4
00 MHz): d=7.61 (d, J=8.8 Hz, 1H), 7.23 (d, J=2.2 Hz, 1H), 7.17
(
dd, J =2.3 Hz, J =8.7 Hz, 1H), 6.27 (q, J=1.1 Hz, 1H), 4.90–4.78
1 2
(
m, 1H), 2.47–2.40 (m, 3H), 1.82–1.61 (m, 2H), 1.41–1.35 (m, 3H),
This work was supported by project “Biotransformations for phar-
maceutical and cosmetics industry” No. POIG.01.03.01–00–158/
09–01 part-financed by the European Union within the European
Regional Development Fund and by Polish National Science
Center project No. 2013/11/B/ST5/02199.
1
3
1
1
9
(
5
.04–0.96 (t, 3H); C NMR (CDCl , 100 MHz): d=160.4, 154.1, 153.4,
3
52.4, 151.8, 125.4, 117.8, 117.4, 114.5, 109.9, 78.4, 28.7, 19.2, 18.7,
.5; UV/Vis (lmax, nm, phosphate buffer pH 7.4, loge): 215 (4.1), 275
3.9) 310 (3.9); elemental analysis calcd (%) for C H O : C 65.21, H
15 16 5
.84; found: C 65.38, H 5.87; HPLC analysis t =12.1 min (AD-H
R
Chiralpak).
Keywords: enantioselectivity · fluorescent probes · fluorogenic
assay · high-throughput screening · pseudoenantiomers
(
R)-2-Butyl-(2-oxo-4-trifluoromethyl-2H-chromen-7-yl) carbonate
(
(
R)-2: The procedure was applied starting with (R)-butan-2-ol
111 mg, 1.5 mmol) and 7-hydroxy-4-trifluoromethyl-2H-chromen-2-
[
[
2] B. Martín-Matute, M. Edin, K. Bogµr, J.-E. Bäckvall, Angew. Chem. Int. Ed.
one (690 mg, 2 mmol) to yield carbonate (R)-6 as a white solid;
yield 214.1 mg (43%); m.p. 101–1028C; [a] =À9.3 (c=1.0, CHCl );
D
3
1
H NMR (CDCl , 400 MHz): d=7.75 (dq, J =1.8 Hz, J =8.8 Hz, 1H),
3
1
2
7
.34 (d, J =2.2 Hz, 1H), 7.28–7.20 (m, 1H), 6.78 (s, 1H), 4.91–4.79
1
(
m, 1H), 1.83–1.63 (m, 2H), 1.38 (d, J=6.4 Hz, 3H), 1.01 (t, J=
[
1
3
7
1
9
.5 Hz, 3H); C NMR (CDCl , 100 MHz): d=158.4, 155.1, 154.4,
3
52.1, 126.3, 122.8, 120.0, 118.3, 115.4, 111.2, 110.5, 78.8, 28.6, 19.2,
.5; UV/Vis (lmax, nm, phosphate buffer pH 7.4, loge): 215 (3.8), 285
3.7), 315 (3.7); elemental analysis calcd (%) for C H F O : C 54.55,
15 13 3 5
(
[
[
[
H 3.97; found: C 54.78, H 3.96.
(
S)-2-Butyl-(2-oxo-4-trifluoromethyl-2H-chromen-7-yl) carbonate
(
(
S)-2: The procedure was applied starting with (S)-butan-2-ol
111 mg, 1.5 mmol) and 7-hydroxy-4-trifluoromethyl-2H-chromen-2-
one (690 mg, 2 mmol) to yield carbonate (S)-6 as a white solid;
[
10] F. Morís-Varas, A. Shah, J. Aikens, N. P. Nadkarni, J. D. Rozzell, D. C. Demi-
yield 177.8 mg (36%); m.p. 101–1028C; [a] =+9.8 (c=1.0, CHCl );
D
3
rjian, Bioorg. Med. Chem. 1999, 7, 2183–2188.
1
H NMR (CDCl , 400 MHz): d=7.75 (dq, J =1.8 Hz, J =8.9 Hz, 1H),
3
1
2
7
.34 (d, J=2.2 Hz, 1H), 7.28–7.21 (m, 1H), 6.78 (d, J=0.7 Hz, 1H),
ChemBioChem 2016, 17, 71 – 76
75
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim